BACKGROUND: While changes in blood pressure (BP) are independently associated with cardiovascular events, less is known about the association between changes in BP and subsequent changes in renal function in adults with an estimated glomerular filtration rate (eGFR) of >60 ml/min/1.73 m2. METHODS: The present study included 3,920 participants in the Multi-Ethnic Study of Atherosclerosis (MESA) study who had ≥2 BP measurements during the first 5 years of MESA and had eGFR measurements at both year 5 and 10. Change in BP was estimated as the annualized slope of BP between year 0 and 5 based on linear mixed models (mean number of measurements = 4.0). Participants were then grouped into 1 of 3 categories based on the distribution of systolic BP (SBP), diastolic BP (DBP), and pulse pressure (PP) change (top 20%, middle 21-79%, bottom 20%). We calculated eGFR from cystatin C (ml/min/1.73 m2), estimated annual change in eGFR (ml/min/1.73 m2/year), and defined rapid kidney function decline as a >30% decrease in eGFR from year 5 to 10. We used multivariable logistic regression adjusting for year 0 demographic and clinical characteristics, including eGFR and BP, to determine associations of BP change with rapid kidney function decline. RESULTS: Median age was 59 [interquartile range (IQR): 52, 67] and median eGFR at year 0 was 95.5 (IQR: 81.7, 105.9) ml/min/1.73 m2. Median SBP at year 0 was 111, 121, and 147 mm Hg for increasing, stable, and decreasing SBP change, respectively. Increasing SBP and widening PP change were each associated with higher odds of rapid kidney function decline compared with stable SBP and PP groups, respectively [odds ratio, OR 1.7 (95% confidence interval, CI 1.3, 2.4) for SBP; OR 1.4 (95% CI 1.1, 1.9) for PP]. Decreasing SBP was associated with rapid kidney function decline after adjusting for all covariates except for year 0 BP [OR 1.4 (95% CI 1.0, 1.8)], but this association was no longer statistically significant after adjustment for year 0 BP. There were no significant associations between DBP change and rapid decline in the fully adjusted models. Similar findings were seen with annual change in eGFR. CONCLUSIONS: Increasing SBP and widening PP over time were associated with greater risk for accelerated kidney function decline even at BP levels below established hypertension thresholds.
BACKGROUND: While changes in blood pressure (BP) are independently associated with cardiovascular events, less is known about the association between changes in BP and subsequent changes in renal function in adults with an estimated glomerular filtration rate (eGFR) of >60 ml/min/1.73 m2. METHODS: The present study included 3,920 participants in the Multi-Ethnic Study of Atherosclerosis (MESA) study who had ≥2 BP measurements during the first 5 years of MESA and had eGFR measurements at both year 5 and 10. Change in BP was estimated as the annualized slope of BP between year 0 and 5 based on linear mixed models (mean number of measurements = 4.0). Participants were then grouped into 1 of 3 categories based on the distribution of systolic BP (SBP), diastolic BP (DBP), and pulse pressure (PP) change (top 20%, middle 21-79%, bottom 20%). We calculated eGFR from cystatin C (ml/min/1.73 m2), estimated annual change in eGFR (ml/min/1.73 m2/year), and defined rapid kidney function decline as a >30% decrease in eGFR from year 5 to 10. We used multivariable logistic regression adjusting for year 0 demographic and clinical characteristics, including eGFR and BP, to determine associations of BP change with rapid kidney function decline. RESULTS: Median age was 59 [interquartile range (IQR): 52, 67] and median eGFR at year 0 was 95.5 (IQR: 81.7, 105.9) ml/min/1.73 m2. Median SBP at year 0 was 111, 121, and 147 mm Hg for increasing, stable, and decreasing SBP change, respectively. Increasing SBP and widening PP change were each associated with higher odds of rapid kidney function decline compared with stable SBP and PP groups, respectively [odds ratio, OR 1.7 (95% confidence interval, CI 1.3, 2.4) for SBP; OR 1.4 (95% CI 1.1, 1.9) for PP]. Decreasing SBP was associated with rapid kidney function decline after adjusting for all covariates except for year 0 BP [OR 1.4 (95% CI 1.0, 1.8)], but this association was no longer statistically significant after adjustment for year 0 BP. There were no significant associations between DBP change and rapid decline in the fully adjusted models. Similar findings were seen with annual change in eGFR. CONCLUSIONS: Increasing SBP and widening PP over time were associated with greater risk for accelerated kidney function decline even at BP levels below established hypertension thresholds.
Authors: Amanda H Anderson; Wei Yang; Raymond R Townsend; Qiang Pan; Glenn M Chertow; John W Kusek; Jeanne Charleston; Jiang He; RadhaKrishna Kallem; James P Lash; Edgar R Miller; Mahboob Rahman; Susan Steigerwalt; Matthew Weir; Jackson T Wright; Harold I Feldman Journal: Ann Intern Med Date: 2015-02-17 Impact factor: 25.391
Authors: William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi Journal: N Engl J Med Date: 2010-03-14 Impact factor: 91.245
Authors: H M Perry; J P Miller; J R Fornoff; J D Baty; M P Sambhi; G Rutan; D W Moskowitz; S E Carmody Journal: Hypertension Date: 1995-04 Impact factor: 10.190
Authors: Carmen A Peralta; Leslie A McClure; Rebecca Scherzer; Michelle C Odden; Carole L White; Michael Shlipak; Oscar Benavente; Pablo Pergola Journal: Circulation Date: 2016-01-13 Impact factor: 29.690
Authors: Natalia Petruski-Ivleva; Anthony J Viera; Daichi Shimbo; Paul Muntner; Christy L Avery; Andrea L C Schneider; David Couper; Anna Kucharska-Newton Journal: Hypertension Date: 2016-04-04 Impact factor: 10.190
Authors: M J Klag; P K Whelton; B L Randall; J D Neaton; F L Brancati; C E Ford; N B Shulman; J Stamler Journal: N Engl J Med Date: 1996-01-04 Impact factor: 91.245
Authors: Xinfang Xie; Emily Atkins; Jicheng Lv; Alexander Bennett; Bruce Neal; Toshiharu Ninomiya; Mark Woodward; Stephen MacMahon; Fiona Turnbull; Graham S Hillis; John Chalmers; Jonathan Mant; Abdul Salam; Kazem Rahimi; Vlado Perkovic; Anthony Rodgers Journal: Lancet Date: 2015-11-07 Impact factor: 79.321
Authors: Anna Malkina; Ronit Katz; Michael G Shlipak; Joachim H Ix; Ian H de Boer; Mark J Sarnak; Matthew Allison; Holly J Kramer; Julie Lin; David Siscovick; Carmen A Peralta Journal: Open J Endocr Metab Dis Date: 2013-05-23
Authors: Zhi Yu; Josef Coresh; Guanghao Qi; Morgan Grams; Eric Boerwinkle; Harold Snieder; Alexander Teumer; Cristian Pattaro; Anna Köttgen; Nilanjan Chatterjee; Adrienne Tin Journal: Kidney Int Date: 2020-05-23 Impact factor: 10.612
Authors: Jie Zheng; Yuemiao Zhang; Humaira Rasheed; Venexia Walker; Yuka Sugawara; Jiachen Li; Yue Leng; Benjamin Elsworth; Robyn E Wootton; Si Fang; Qian Yang; Stephen Burgess; Philip C Haycock; Maria Carolina Borges; Yoonsu Cho; Rebecca Carnegie; Amy Howell; Jamie Robinson; Laurent F Thomas; Ben Michael Brumpton; Kristian Hveem; Stein Hallan; Nora Franceschini; Andrew P Morris; Anna Köttgen; Cristian Pattaro; Matthias Wuttke; Masayuki Yamamoto; Naoki Kashihara; Masato Akiyama; Masahiro Kanai; Koichi Matsuda; Yoichiro Kamatani; Yukinori Okada; Robin Walters; Iona Y Millwood; Zhengming Chen; George Davey Smith; Sean Barbour; Canqing Yu; Bjørn Olav Åsvold; Hong Zhang; Tom R Gaunt Journal: Int J Epidemiol Date: 2021-10-20 Impact factor: 7.196
Authors: Susann Kobus; Alexandra M Buehne; Simone Kathemann; Anja K Buescher; Elke Lainka Journal: Int J Environ Res Public Health Date: 2022-05-27 Impact factor: 4.614
Authors: Lama Ghazi; Daichi Shimbo; David R Jacobs; Holly Kramer; Jordana B Cohen; Paul Muntner; Yuichiro Yano; Paul E Drawz Journal: Kidney Med Date: 2021-12-23